CellaVision AB
STO:CEVI

Watchlist Manager

CellaVision AB

STO:CEVI

Watchlist

Dividends

Price: 221 SEK Market Closed

Market Cap: 5.3B SEK

Have any thoughts about
CellaVision AB?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication

Add Price Alert

Price Target:

Last Price: 221 SEK

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

CEVI Alert

CellaVision AB

221

0 (0%)

52 Week Range	183.3603 296.5
Price Target

We'll email you a reminder when the closing price reaches SEK.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

CellaVision AB

What unique competitive advantages
does CellaVision AB hold over its rivals?

What risks and challenges
does CellaVision AB face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of CellaVision AB.

What unique competitive advantages
does CellaVision AB hold over its rivals?

What risks and challenges
does CellaVision AB face in the near future?

Has there been any significant insider trading activity
in CellaVision AB recently?

Summarize the latest earnings call
of CellaVision AB.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for CellaVision AB.

Provide P/S
for CellaVision AB.

Provide P/E
for CellaVision AB.

Provide P/OCF
for CellaVision AB.

Provide P/FCFE
for CellaVision AB.

Provide P/B
for CellaVision AB.

Provide EV/S
for CellaVision AB.

Provide EV/GP
for CellaVision AB.

Provide EV/EBITDA
for CellaVision AB.

Provide EV/EBIT
for CellaVision AB.

Provide EV/OCF
for CellaVision AB.

Provide EV/FCFF
for CellaVision AB.

Provide EV/IC
for CellaVision AB.

Show me price targets
for CellaVision AB made by professional analysts.

What are the Revenue projections
for CellaVision AB?

How accurate were the past Revenue estimates
for CellaVision AB?

What are the Net Income projections
for CellaVision AB?

How accurate were the past Net Income estimates
for CellaVision AB?

What are the EPS projections
for CellaVision AB?

How accurate were the past EPS estimates
for CellaVision AB?

What are the EBIT projections
for CellaVision AB?

How accurate were the past EBIT estimates
for CellaVision AB?

Compare the revenue forecasts
for CellaVision AB with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of CellaVision AB and its key competitors using the latest financial data.

Compare historical revenue growth rates
of CellaVision AB against its competitors.

Analyze the profit margins
(gross, operating, and net) of CellaVision AB compared to its peers.

Compare the P/E ratios
of CellaVision AB against its peers.

Discuss the investment returns and shareholder value creation
comparing CellaVision AB with its peers.

Analyze the financial leverage
of CellaVision AB compared to its main competitors.

Show all profitability ratios
for CellaVision AB.

Provide ROE
for CellaVision AB.

Provide ROA
for CellaVision AB.

Provide ROIC
for CellaVision AB.

Provide ROCE
for CellaVision AB.

Provide Gross Margin
for CellaVision AB.

Provide Operating Margin
for CellaVision AB.

Provide Net Margin
for CellaVision AB.

Provide FCF Margin
for CellaVision AB.

Show all solvency ratios
for CellaVision AB.

Provide D/E Ratio
for CellaVision AB.

Provide D/A Ratio
for CellaVision AB.

Provide Interest Coverage Ratio
for CellaVision AB.

Provide Altman Z-Score Ratio
for CellaVision AB.

Provide Quick Ratio
for CellaVision AB.

Provide Current Ratio
for CellaVision AB.

Provide Cash Ratio
for CellaVision AB.

What is the historical Revenue growth
over the last 5 years for CellaVision AB?

What is the historical Net Income growth
over the last 5 years for CellaVision AB?

What is the current Free Cash Flow
of CellaVision AB?

Discuss the annual earnings per share (EPS)
trend over the past five years for CellaVision AB.

P/S
Price to Sales

7.2

Current

8.2

Median

2.3

Industry

Lower than median

Higher than industry value

Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.

P/S

7.2

Market Cap

5.3B SEK

Revenue

737.2m SEK

All Countries

Forward Multiples

		Market Cap	P/S
SE	CellaVision AB STO:CEVI	5.3B SEK	7.2
US	Abbott Laboratories NYSE:ABT	199B USD	4.8
US	Intuitive Surgical Inc NASDAQ:ISRG	191.3B USD	24.3
US	Stryker Corp NYSE:SYK	141.3B USD	6.4
US	Boston Scientific Corp NYSE:BSX	134.2B USD	8.4
IE	Medtronic PLC NYSE:MDT	104.6B USD	3.2
US	Becton Dickinson and Co NYSE:BDX	65.6B USD	3.3
DE	Siemens Healthineers AG XETRA:SHL	58.1B EUR	2.6
US	Edwards Lifesciences Corp NYSE:EW	44.5B USD	7.9
CN	Shenzhen Mindray Bio-Medical Electronics Co Ltd SZSE:300760	310B CNY	8.4
US	GE Healthcare Technologies Inc NASDAQ:GEHC	36.3B USD	1.9

			Revenue Growth	P/S to Growth
SE	CellaVision AB STO:CEVI	Average P/S: 7.1 7.2	46%	0.2
US	Abbott Laboratories NYSE:ABT	4.8	22%	0.2
US	Intuitive Surgical Inc NASDAQ:ISRG	24.3	58%	0.4
US	Stryker Corp NYSE:SYK	6.4	30%	0.2
US	Boston Scientific Corp NYSE:BSX	8.4	46%	0.2
IE	Medtronic PLC NYSE:MDT	3.2	15%	0.2
US	Becton Dickinson and Co NYSE:BDX	3.3	20%	0.2
DE	Siemens Healthineers AG XETRA:SHL	2.6	18%	0.1
US	Edwards Lifesciences Corp NYSE:EW	7.9	11%	0.7
CN	Shenzhen Mindray Bio-Medical Electronics Co Ltd SZSE:300760	8.4	64%	0.1
US	GE Healthcare Technologies Inc NASDAQ:GEHC	1.9	11%	0.2

P/S Forward Multiples

Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

P/S

2-Years Forward

P/S

6.1

3-Years Forward

P/S

5.3

	Franklin Covey Co NYSE:FC	36.87 USD 1.57%
	Mohawk Industries Inc NYSE:MHK	120.19 USD 0.54%
	Ardmore Shipping Corp NYSE:ASC	12.12 USD 2.02%
	ASGN Inc NYSE:ASGN	84.15 USD 0.71%
	Skyworks Solutions Inc NASDAQ:SWKS	90.35 USD 0.18%
	Weatherford International PLC NASDAQ:WFRD	68.07 USD 1.95%

	Johnson & Johnson NYSE:JNJ	145.85 USD 0.4%
	Bank of America Corp NYSE:BAC	44.38 USD 1.12%
	Mastercard Inc NYSE:MA	535.71 USD 1.28%
	Salesforce Inc NYSE:CRM	344.43 USD 0.45%
	Abbvie Inc NYSE:ABBV	180 USD 0.9%
	Home Depot Inc NYSE:HD	396.14 USD 0.94%

	Arista Networks Inc NYSE:ANET	114.65 USD 1.38%
	Visa Inc NYSE:V	320.65 USD 1.08%
	Texas Pacific Land Corp NYSE:TPL	1 161.2 USD 1.91%
	KLA Corp NASDAQ:KLAC	650.53 USD 0.39%
	Manhattan Associates Inc NASDAQ:MANH	282.27 USD 1.24%
	Pinduoduo Inc NASDAQ:PDD	99.72 USD -0.86%

	Salesforce Inc NYSE:CRM	344.43 USD 0.45%
	Accenture PLC NYSE:ACN	361.63 USD 0.8%
	ServiceNow Inc NYSE:NOW	1 105.56 USD 1.59%
	EOG Resources Inc NYSE:EOG	120.83 USD 0.82%
	Copart Inc NASDAQ:CPRT	59.11 USD 1.29%
	Applied Materials Inc NASDAQ:AMAT	168.37 USD 0.54%

CellaVision AB
STO:CEVI

P/S
Price to Sales

P/S Forward Multiples

See Also

Company

Help

Tools

Stocks

CellaVision AB STO:CEVI

P/S Price to Sales

P/S Forward Multiples

See Also

Company

Help

Tools

Stocks

CellaVision AB
STO:CEVI

P/S
Price to Sales